Introduction
Sialidases also termed neuraminidases (enzyme code 3. 2. 1. 18) are enzymes that catalyse removal of terminal sialic acid residues such as α-D-N-acetylneuraminic acid (Neu5Ac) from glycoconjugates . They are widely distributed in mammals (Cross et al., 2012) , bacteria (Connaris et al., 2009) , viruses (Plattet and Plemper, 2013; Suzuki et al., 1985; Takahashi et al., 2010) , and protozoa (Bermejo et al., 2013) . Removal of sialic acid induces protein conformational changes and electric charge changes, resulting in regulation of biological processes such as endogenous sialidase activity-dependent synaptogenesis (Isaeva et al., 2010) , cell malignancy caused by cellular sialidase overexpression (Koseki et al., 2012; Tringali et al., 2012) , uptake of apoptotic lymphocytes (Meesmann et al., 2010) , and loss of receptor binding sites of pathogens (Bermejo et al., 2013; Plattet and Plemper, 2013; Suzuki et al., 1985; Takahashi et al., 2010) . Therefore, detection of sialidase activity is important for the study of biological phenomena.
An immunochemical method using a specific anti-virus antibody has generally been used for visualisation of virus-infected cells. However, it takes several weeks or months to prepare a specific antibody of each virus or strain. Paramyxoviruses such as Sendai virus (SV) and Newcastle disease virus show sialidase activity (Suzuki et al., 1985) . We assumed that a highly sensitive sialidase substrate, which is deposited at the location of sialidase activity by generating an insoluble fluorescent compound, would enable histochemical visualisation of virus-infected cells by an easy protocol and in a short time, with no requirement for a specific antibody and fixation of cells.
Several methods for measurement of viral sialidase activity have been established. In the thiobarbituric acid (TBA) assay, native sialoglycoconjugates such as bovine fetuin and sialyllactose are used as sialidase substrates. After sialic acid molecules have been released from the sialoglycoconjugates by sialidase reaction, they are oxidised and react with TBA to generate a red chromophore (Nayak and Reichl, 2004; Romero et al., 1997) . The TBA assay has been widely used by virologists for measurement of viral sialidase activity, but it is difficult to examine sialidase activities of many samples because of the complex multiple steps and arsenate usage for the protocol of the assay. For representative fluorescent sialidase substrates, 4-methylumbelliferyl-Neu5Ac (4MU-Neu5Ac), 1,2-dioxetane derivative of Neu5Ac (NA-STAR), and 5-bromo-4-chloroindol-3-yl-Neu5Ac (X-Neu5Ac) have been mostly used because of their commercial availability and an easy protocol of one step. 4MU-Neu5Ac is divided by sialidase reaction into Neu5Ac and soluble fluorescent 4-methylumbelliferone (Nayak and Reichl, 2004; Takahashi et al., 2010) . NA-STAR is a chemiluminescencebased substrate that is highly sensitive and can be used to monitor neuraminidase inhibitor-resistant influenza A viruses (Buxton et al., 2000) . However, these substrates cannot histochemically stain sialidase activity. On the other hand, X-Neu5Ac forms an insoluble compound by oxidation after sialidase reaction and can histochemically stain localisation of sialidase activity . However, X-Neu5Ac has low sensitivity and easily detects unspecific signals other than those from the infected cells such as signals from influenza virus-infected cells (Suzuki et al., 2005) because it requires a long time and high concentration to visualise sialidase activity, which increase nonspecific signals derived from endogenous cellular sialidase and progeny virus sialidase continuously budded from the infected cells during reaction with X-Neu5Ac. To enhance the sensitivity of X-Neu5Ac, a sensitiser such as Fast Red Violet LB (FRV LB) as a coupler to form an azo dye is used with X-Neu5Ac (Fujii et al., 1993; Saito et al., 2002; Suzuki et al., 2005) . However, nonspecific staining other than staining of the infected cells is easily enhanced by FRV LB.
Since there has been no highly sensitive sialidase substrate with an insoluble fluorescent compound, we have developed a new fluorescent sialidase probe that is a useful tool for histochemical visualisation of sialidase activity. A benzothiazolylphenol derivative named BTP3 is a crystalline, insoluble, acid-resistant, and fluorescently-stable compound (Ex/Em¼372/526 nm) (Kim et al., 2009; Minami et al., 2014; Otsubo et al., 2013) . Its sufficiently large Stokes' shift is advantageous for preventing effects of excitation light, self-absorption, and noise fluorescence derived from cells and tissues. We have synthesised a BTP3 derivative (BTP3-Neu5Ac) that was conjugated to Neu5Ac as a sialidase substrate. Although BTP3-Neu5Ac itself is not fluorescent, BTP3 should be locally deposited at the location of sialidase activity after removal of Neu5Ac by sialidase (Fig. 1) . In our previous study, we showed that BTP3-Neu5Ac was able to histochemically stain mammalian sialidase activity in tissue sections (Minami et al., 2014) . In the present study, we applied BTP3-Neu5Ac to histochemical visualisation of SV sialidase activity.
SV, alternatively known as a murine parainfluenza virus, belongs to the genus Respirovirus of the Paramyxoviridae family, harbouring non-segmented negative sense RNA. Hemagglutininneuraminidase (HN) glycoprotein and fusion (F) glycoprotein are expressed on the virus envelope and play important roles in SV invasion into host cells. HN glycoprotein recognises sialic acid as a receptor and also shows sialidase activity at low pH. The sialidase activity is thought to assist virus budding by removal of sialic acid on the host cells and to prevent aggregation of virus particles by removal of sialic acid on the viral surface glycoproteins. Both HN and F glycoproteins accumulate on the surface of infected cells, being ready to produce progeny viruses (Faísca and Desmecht, 2007; Kohama et al., 1981; Segawa et al., 2003; Suzuki et al., 1985) .
SV has been extensively studied as a pathogen against animals and as an experimental material in biotechnology. SV infection is highly contagious and mortal in rodents, causing severe pneumonia and bronchiolitis. Once SV infection occurs, the virus spreads rapidly to other sensitive animals. These animals die of SV infection (Faísca and Desmecht, 2007) . A large number of researchers have expected that the high infectivity and cell cytotoxicity of SV and no pathogenicity in humans can be taken advantage of as an oncolytic virus and a vaccine candidate with other antigens (Faísca and Desmecht, 2007; Morodomi et al., 2012) . Several detection systems have been established to detect SV-infected cells for virological research and to provide proper diagnosis of SV infection disease. The most widely utilised methods are plaque forming assays because a specific anti-SV antibody is not required. Cells, such as Lewis-lung carcinoma monkey kidney LLC-MK 2 cells, are infected with clinical samples and cultured in agarose gel-containing medium for several days until the appearance of plaques. This method can be applied to both measurement of SV infection titre and isolation of a cloned virus (Sugita, 1981) . Another diagnostic system is a serological assay in which the anti-SV antibody titre in mouse serum is examined with an enzyme-linked immunosorbent assay (ELISA) (Zenner and Regnault, 2000) . Reverse transcriptase-polymerase chain reaction (RT-PCR) is also one of the choices, and it has enabled detection of the SV gene with the highest sensitivity (Wagner et al., 2003) . Together with these existing methods, the use of BTP3-Neu5Ac could contribute to the progress of virological and biotechnological studies on SV, such as the development of an oncolytic virus, gene therapy vector, and vaccine candidate.
In the present study, to establish a protocol of BTP3-Neu5Ac usage for SV research, we attempted fluorescently histochemical visualisation of SV-infected cells through sialidase activity of HN glycoproteins on the cell surface.
Results

Rapid and sensitive fluorescent histochemical staining of SV sialidase with BTP3-Neu5Ac
Firstly, we investigated the applicability of BTP3-Neu5Ac as a substrate of SV sialidase. Detection of SV sialidase activity has been performed at acidic pH (Segawa et al., 2003) . To determine the optimal pH for SV sialidase reaction with BTP3-Neu5Ac, a SVblotted polyvinylidenedifluoride (PVDF) membrane was treated with BTP3-Neu5Ac at pH 4.5, 5.0, 5.5, or 6.0. The SV-blotted region showed the strongest fluorescence at pH 4.5 ( Fig. 2A) . Next, we compared the sensitivity of BTP3-Neu5Ac against SV sialidase to that of a conventional sialidase substrate, X-Neu5Ac. A serially diluted SV-blotted PVDF membrane was treated with 10 μM BTP3-Neu5Ac and 100 μM X-Neu5Ac. After substrate reaction for 10 min at room temperature, BTP3-Neu5Ac clearly stained SV-blotted regions until 2 -2 hemagglutination units (HAU) (Fig. 2B) . SV dose-dependent fluorescence with BTP3-Neu5Ac suggested that BTP3-Neu5Ac was specifically reactive to SV. On the other hand, Fig. 1 . Fluorescent visualisation scheme of sialidase activity with BTP3-Neu5Ac.
24-h incubation with X-Neu5Ac visualised SV blots, but 10-min incubation did not (Fig. 2C ). These results indicated that BTP3-Neu5Ac was a much more rapid and more sensitive substrate than X-Neu5Ac for SV sialidase.
Fluorescent visualisation of SV-infected cells with BTP3-Neu5Ac
We attempted fluorescent histochemical visualisation of SVinfected cells with BTP3-Neu5Ac. SV-infected LLC-MK 2 cells at 24 h after infection were treated with 10 μM BTP3-Neu5Ac at 37 1C for 5 min. Green fluorescent staining was observed in a dose-dependent manner of SV infection (Fig. 3A) . To confirm that the fluorescence was dependent on sialidase activity, the SV-infected cells were treated with BTP3-Neu5Ac in the presence of 1 mM 2,3-dehydro-2-deoxy-Neu5Ac (DANA), a pan-sialidase inhibitor. Fluorescence was not generated under the condition of DANA treatment (Fig. 3B) , although the SV-infected cells were immunologically detected (supplementary Fig. 1 ). This result indicated that generation of fluorescence by BTP3-Neu5Ac reaction was dependent on sialidase activity of the SV-infected cells. We also confirmed that the fluorescence was dependent on SV sialidase activity by using Cos-7 cells transfected with an expression vector coding the SV HN (HNsv) gene or an empty vector. At 48 h post transfection, the cells were treated with 10 μM BTP3-Neu5Ac at 37 1C for 5 min. Green fluorescence was observed in the cells transfected with the HNsv gene but not in the cells transfected with the empty vector (Fig. 3C ), indicating that sialidase activity of HNsv produced the green fluorescent staining with BTP3-Neu5Ac treatment. To qualify the specificity of staining with BTP3-Neu5Ac on SV-infected cells, we compared fluorescent histochemical staining with BTP3-Neu5Ac to immunohistochemical staining with anti-SV antibody for detection of SV-infected cells. SVinfected LLC-MK 2 cells were fixed with 4% paraformaldehyde and immunostained, followed by 10 μM BTP3-Neu5Ac treatment. The cells stained with BTP3-Neu5Ac were also immunostained with a rabbit anti-SV polyclonal antibody (Fig. 3D) . In order to compare the sensitivities of BTP3-Neu5Ac and X-Neu5Ac, we tried to detect SVinfected cells with X-Neu5Ac at 24 h post infection. SV-infected cells were not stained by 5-min or 1-h treatment with 1 mM X-Neu5Ac. Four-hour incubation with X-Neu5Ac resulted generation of a blue pigment that covered the entire cell-cultured well, but staining of SV-infected cells was not distinguished (supplementary Fig. 2) . On the other hand, SV-infected cells could be detected in 10 min by using 10 mM BTP3-Neu5Ac, the concentration of which was much smaller than that of X-Neu5Ac. Thus, BTP3-Neu5Ac could visualise SV-infected cells more sensitively than X-Neu5Ac could. These results showed that SV-infected cells were specifically stained with BTP3-Neu5Ac.
Fluorescent histochemical visualisation of lung tissues from SV-infected mice with BTP3-Neu5Ac SV is known to infect mice and cause mortal respiratory symptoms (Faísca and Desmecht, 2007) . We planned fluorescent histochemical visualisation of SV-infected cells in lung sections from virus-infected mice with BTP3-Neu5Ac. Female BALB/c mice were intranasally challenged with SV. At 24 h post infection, lungs of the infected mice were collected. After fixation with 4% paraformaldehyde, lung sections of 10 μm in thickness were treated with 5 μM BTP3-Neu5Ac for 10 min. Clear green fluorescence was observed inside bronchioles (BRs) in SV-infected lung sections but not in lung sections from non-infected mice (Fig. 4A) . It has been reported that SV infects the bronchiolar epithelium when mice are intranasally challenged with SV (Castleman et al., 1987) , coinciding with the staining site of BTP3-Neu5Ac in lungs of SV-infected mice. To confirm that the SV-infected bronchiolar epithelium was specifically stained with BTP3-Neu5Ac, we compared double-staining in SV-infected lung section with BTP3-Neu5Ac and with a rabbit anti-SV polyclonal antibody. The bronchiolar epithelium stained with BTP3-Neu5Ac was also stained with anti-SV antibody (Fig. 4B) . Co-localisation of the both stainings indicated that BTP3-Neu5Ac specifically stained SVinfected regions in tissues.
In the present study, we concluded that BTP3-Neu5Ac fluorescently visualised SV sialidase activity and SV-infected regions in vitro and in SV-infected mouse lung sections in a short time (within several minutes), in addition to no requirement of specific anti-SV antibodies.
Discussion and conclusion
We have developed a new fluorescent sialidase substrate, BTP3-Neu5Ac, which enables sensitive histochemical staining of sialidase activity. In the present study, we were able to rapidly and sensitively visualise the SV-infected cells with BTP3-Neu5Ac.
Normally, in order to histochemically stain SV-infected cells, immunostaining with an anti-SV antibody would be the first choice in most cases. A specific anti-SV antibody and an enzymeor fluorescence-conjugated secondary antibody must therefore be prepared. Additionally, before primary antibody reaction, cells must be fixed and permeabilised with a detergent. Reaction times with primary and secondary antibodies take at least 1 h (30 min for each antibody) at room temperature (Fukushima et al., 2011) . Thus, it takes more than 1 h to complete immunostaining. However, when BTP3-Neu5Ac is used, live infected cells can be stained in several minutes only (within 10 min) by an easy protocol to exchange cultured supernatant into the substrate solution.
SV widely infects many cell lines and shows high cytotoxicity, but it causes no clinical symptoms in humans (Castleman et al., 1987) . Reverse genetics system has been positioning SV as a biotechnological tool (Segawa et al., 2003) . Recently, recombinant SV has been utilised as an oncolytic virus, as a vector in gene therapy against Fabry's disease (Kawagoe et al., 2013) and Alzheimer's disease (Iwasaki et al., 2012) , and as a vaccinating vector against respiratory syncytial virus (Jones et al., 2012), human parainfluenza virus type 1 and type 3 (Faísca and Desmecht, 2007; Mason et al., 2013; Sealy et al., 2010) , and human immunodeficiency virus (Hara et al., 2011) . For the purpose of easy investigation of SV transfection efficacy and actual infection, a green fluorescent protein (GFP) gene is often introduced into recombinant SV genetically. The GFP should enable detection of SV-transfected regions, but GFP insertion might decrease efficient virus proliferation (Agungpriyono et al., 2000) . BTP3-Neu5Ac could solve such a problem because it can histochemically visualise cells or tissues infected with SV without the GFP gene in a short time.
SV research could spread more and more widely. A system for more efficient evaluation of SV transfection is essential. We expect that BTP3-Neu5Ac will contribute to further development and more rapid progress of SV studies such as virological sialidase studies and studies to develop an oncolytic virus, a gene therapy vector, and a vaccinating vector. BTP3-Neu5Ac could be an epochmaking sialidase substrate in SV research, with no requirement of cell or tissue fixation and immunochemical reagents. As we previously reported, BTP3-Neu5Ac derivatives are reactive to mammalian (mouse, rat, and human) and bacterial sialidases (Arthrobacter ureafaciens) (Minami et al., 2014) , which means that BTP3-Neu5Ac has a broad spectrum in sialidase reaction. In this study, we focused on SV as a representative virus that has sialidase. Under the conditions in the present study, BTP3-Neu5Ac could be used for specifically staining SV-infected cells without detection of endogenous mammalian sialidase because of the short time reaction. We are now studying the usefulness of BTP3-Neu5Ac for other viruses that have sialidase, such as Newcastle disease virus, human parainfluenza virus, mumps virus, and influenza virus. We expect that BTP3-Neu5Ac will contribute to further virological study in the future.
Materials and methods
Chemicals
BTP3-Neu5Ac was synthesised as previously described (Minami et al., 2014) . The following compounds were acquired from the indicated vendors. X-Neu5Ac and DANA were purchased from Peptide Industry Inc., Osaka, Japan, and Tokyo Chemical Industry, Co., Ltd., Tokyo, Japan, respectively.
Cells and viruses
Lewis lung carcinoma-monkey kidney LLC-MK 2 cells were maintained in Eagle's minimum essential medium supplemented with 5% foetal bovine serum (FBS). African monkey kidney Cos-7 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% FBS. SV (Z strain) was propagated in 11-day-old embryonated chicken eggs and concentrated with glycerol as described previously (Suzuki et al., 2001a; Suzuki et al., 2001b) .
Antibodies
Rabbit anti-SV polyclonal antibody was prepared by immunisation of rabbits against SV according to previously described method (Suzuki et al., 2001a) . Horseradish peroxidase (HRP)-conjugated Protein A (Sigma-Aldrich, St. Louis, MO) and phycoerythrin (PE)-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology Inc., Dallas, TX) were purchased.
Hemagglutination unit determination
Fifty microliters/well of 2-fold serial dilutions of SV in phosphate-buffered saline (PBS; pH 7.2, 131 mM NaCl, 14 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , and 2.7 mM KCl) was poured into a Ubottom 96-well plate. PBS was used as a negative control without virus. Fifty microliters/well of 0.5% v/v human red blood cell suspension in PBS was added. A plate was incubated at 4 1C for 2 h. The reciprocal of the highest SV dilution showing hemagglutination was defined as HAU. Visualisation of dot-blotted SV on a membrane with BTP3-Neu5Ac or X-Neu5Ac
In order to determine the proper pH of SV sialidase detection with BTP3-Neu5Ac, a PVDF membrane was blotted with 2 HAU) in PBS and incubated with 10 μM BTP3-Neu5Ac and 100 μM X-Neu5Ac in 5 mM acetate buffer (pH 4.5) at room temperature for 10 min and 24 h, respectively. Images of the PVDF membranes were obtained by using Lumi Vision PRO HR (AISIN SEIKI Co., Ltd., Aichi, Japan) with DR655YA3 optical filter (Kenko Tokina Co., Ltd., Tokyo, Japan) under ultraviolet (UV) irradiation or an optical condition.
Construction of a expression vector containing the HN gene SV RNA was isolated from virus particles with TRIzol reagent (Invitrogen Corp., Carsbad, CA) according to the manufacturer's instructions. The full length of the HNsv gene (GenBank accession number M30202) was amplified with a TaKaRa RNA PCR ™ kit (AMV) ver. 3.0 (TaKaRa Bio Inc., Shiga, Japan) with specific primers, 5 0 -CGGAATTCCGTGAAAGTGAGGTCGCGCGGTAC-TTTAGCTTT-3 0 and 5 0 -CCATCGATGGCTTAATACTGTGAGAGACGTAA-GAGACTGA-3 0 . pCAGGS-HNsv was constructed by insertion of the HNsv gene into the multicloning region between the EcoR I site and Cla I site of expression plasmid pCAGGS/MCS vector (Takahashi et al., 2010) .
Fluorescent visualisation of HNsv-expressing cells with BTP3-Neu5Ac
A 70% confluent monolayer of Cos-7 cells on a 48-well plate was transfected with pCAGGS-HNsv (300 ng/well) using the transfection reagent TransIT-LT1 (Mirus, Madison, WI) according to manufacturer's instructions. pCAGGS/MCS was used as a negative control. After incubation at 37 1C in 5% CO 2 for 4 h, cells were washed with PBS and cultured in a serum-free medium (SFM), Hybridoma-SFM (Invitrogen Corp, Carlsbad, CA), for 44 h at 37 1C in 5% CO 2 . Cells were washed with PBS and treated with 10 μM BTP3-Neu5Ac in 100 μl/ well of SFM (adjusted to pH 4.5 with 3 N HCl) at 37 1C in 5% CO 2 for 5 min. Cells were washed with PBS and observed with an IX71 fluorescent microscope (Olympus Co., Ltd., Tokyo, Japan) equipped with a fluorescent filter (U-MWU2, DM400, BP336-385, BA420).
Determination of focus-forming units
A confluent monolayer of LLC-MK 2 cells on a 12-well plate was infected with 10-fold serially diluted SV in SFM at room temperature for 1 h, followed by addition of an overlay medium containing 1.2% Avicel s RC-581 NF (FMC Biopolymer, Philadelphia, PA) in SFM. The cells were cultured for 48 h at 37 1C in 5% CO 2 . After removal of the overlay medium, the cells were washed 3 times with PBS and fixed with methanol. The infected cells (foci) were visualised immunologically with rabbit anti-SV serum, and the number was counted to determine focus-forming units (ffu).
Fluorescent visualisation of SV-infected cells with BTP3-Neu5Ac
A confluent monolayer of LLC-MK 2 cells on a 96-well plate was infected with the indicated ffu of SV in 45 μl/well of SFM at 37 1C in 5% CO 2 for 1 h and washed with 100 μl/well of PBS. After culture in 100 μl/well of SFM at 37 1C in 5% CO 2 for 24 h, cells were stained with 10 μM BTP3-Neu5Ac in 45 μl of SFM (pH 4.5) at 37 1C in 5%
CO 2 for 5 min. To confirm sialidase dependency of fluorescent staining with BTP3-Neu5Ac, cells were also stained with 10 μM BTP3-Neu5Ac in 45 μl of SFM (pH 4.5) at 37 1C in 5% CO 2 for 5 min in the presence of 1 mM DANA, a pan-sialidase inhibitor. Then the cells were washed with 100 μl/well of PBS and observed in 100 μl/ well of SFM by using a fluorescent microscope.
Immunostaining of SV-infected cells
In order to confirm that BTP3-Neu5Ac specifically stained SVinfected cells, infected cells were immunostained with a rabbit anti-SV polyclonal antibody. A confluent monolayer of LLC-MK 2 cells on a 96-well plate were infected with the indicated ffu of SV in 45 μl/ well of SFM at 37 1C in 5% CO 2 for 1 h, washed with 100 μl/well of PBS, and cultured in 100 μl/well of SFM at 37 1C in 5% CO 2 for 24 h.
Cells were fixed with 4% paraformaldehyde (Wako Pure Chemical Industries Ltd, Osaka, Japan) at room temperature for 10 min and washed with PBS. The cells were treated with a rabbit anti-SV polyclonal antibody in PBS, followed by PE-conjugated goat antirabbit IgG at room temperature for 30 min each. Then cells were incubated with 10 μM BTP3-Neu5Ac in 45 μl/well of SFM (pH 4.5) at 37 1C in 5% CO 2 for 30 min and washed with PBS. Immunohistochemical images of the infected cells were observed using a fluorescent microscope equipped with fluorescent filter (U-MWIG3, DM570, BP530-550, BA575IF).
Fluorescent histochemical staining of SV-infected mouse lungs with BTP3-Neu5Ac
Mice were infected according to a previous report (Bousse et al., 2002) . Briefly, 6-8-week-old female BALB/c mice were intranasally infected with 1 Â 10 7 ffu of SV in 20 μl/mouse of PBS. At 24 hr postinfection, lungs were collected, treated with 4% paraformaldehyde in PBS, and embedded into Tissue-Tek OCT compound (Sakura Finetechnical Co., Ltd., Tokyo, Japan). After being frozen, lungs were cut in 10-μm-thick sections at À 20 1C with a Shandon Cryotome FE (Thermo Fisher Scientific, Waltham, MA) and fixed with 4% paraformaldehyde for 15 min. Sections were stained with 50 μl/section of 5 μM BTP3-Neu5Ac in 10 mM acetate buffer (pH 4.5) at 37 1C for 10 min and washed with PBS. The sections were observed by using a fluorescent microscope.
Immunohistochemical staining of SV-infected mouse lungs
To confirm SV antigen-positive regions, lung sections were immunostained with a rabbit anti-SV polyclonal antibody. Sections were blocked with 2% goat serum at 4 1C overnight and washed with PBS. The sections were incubated with a rabbit anti-SV polyclonal antibody in 0.2% goat serum in PBS and then with HRP-conjugated Protein A in 0.2% goat serum in PBS at room temperature for 30 min each. Infected regions were visualised as described previously (Suzuki et al., 2001a; Suzuki et al., 2001b; Takahashi et al., 2010) .
